Skip to main content
. Author manuscript; available in PMC: 2020 Nov 29.
Published in final edited form as: Adv Anat Pathol. 2020 May;27(3):114–163. doi: 10.1097/PAP.0000000000000256

Table 5:

Estimated Annual Adenocarcinoma Incidence Stratified by Site of Origin

Tumor Type Estimated Annual Incidence % of All Incident Cases
Breast 268,670 26%
Prostate 164,690 16%
Colorectum 140,250 13%
Lung 124,036 12%
Mullerian 84,358 8%
Pancreatobiliary 72,331 7%
Kidney 58,806 6%
Thyroid 53,990 5%
Upper GI tract 44,566 4%
Hepatocellular carcinoma 34,747 3%